Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon

FDA eases digital mammo approval process

The FDA has decided to streamline the path to market for digital mammography systems by reclassifying the systems from the Class III, or highest risk, to the Class II, or medium risk, category.

NEJM: Inappropriate use of prostate cancer therapy drops as Medicare funding plummets

As Medicare reimbursement for androgen-deprivation therapy (ADT) to treat prostate cancer was slashed in half in 2005, inappropriate use of the therapy fell by 13 percent while appropriate ADT for prostate cancer held steady, according to a study published Nov. 4 the New England Journal of Medicine.

Radiology: U.S. lead in interventional oncology research narrows

The U.S. published the most interventional oncology articles of any country between 1996 and 2008, while Japan and China completed far more clinical research trials as the growth of U.S. research slowed, according to a study published in the November edition of Radiology.

ASTRO: Chemoradiotherapy may be effective head and neck cancer treatment

A combination of stereotactic body radiotherapy with chemotherapy may be effective in controlling and treating head and neck cancers, according to a study presented Nov. 3 at the annual meeting for the American Society for Radiation Oncology (ASTRO) in San Diego.

NEJM: Higher medication spending doesn't indicate better prescribing quality

Medicare patients in regions that spend the most on prescription medications are not necessarily getting better quality care, according to a new study of spending practices from the University of Pittsburgh Graduate School of Public Health. The findings, published in the Nov. 3 issue of the New England Journal of Medicine (NEJM), revealed great variation across the country in both drug spending and the rate of inappropriate prescriptions for the elderly.

ASTRO: Brainlab, Mitsubishi introduce Vero SBRT system

The Vero stereotactic body radiotherapy (SBRT) system, a cooperative partnership between Brainlab and Mitsubishi Heavy Industries, was introduced at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) Oct. 31 to Nov. 4 in San Diego.

KLAS: Radiation delivery systems are evolving, not integrating

Radiation delivery products are evolving to treat cancer more effectively and at an increased pace, according to a report from market research firm KLAS, but integration issues are a limiting factor.

ASTRO: Stereotactic radiotherapy slows pancreatic cancer progression

Stereotactic body radiotherapy may slow progression and ease symptoms of pancreatic cancer in medically inoperable patients, providing patients with no curative treatment options extended survival, according to a study presented November 2 at the annual meeting for the American Society for Radiation Oncology (ASTRO) in San Diego.

Displaying 1497 - 1504 of 2562

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.